Variant report
Variant | nsv1029615 |
---|---|
Chromosome Location | chr6:66399470-66413811 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:189034137..189034728-chr6:66401890..66402666,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576874798 | chr6:66399623-66399624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141914960 | chr6:66399647-66399648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs113936143 | chr6:66399661-66399662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181333726 | chr6:66399669-66399670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553786790 | chr6:66399685-66399686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546690166 | chr6:66399693-66399694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9453366 | chr6:66399710-66399711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559862931 | chr6:66399735-66399736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138109199 | chr6:66399791-66399792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549256496 | chr6:66399825-66399826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565994534 | chr6:66399827-66399828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185992456 | chr6:66399834-66399835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6902244 | chr6:66399845-66399846 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs571437602 | chr6:66399862-66399863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534009741 | chr6:66399863-66399864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188990921 | chr6:66399867-66399868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149532722 | chr6:66399884-66399885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536289110 | chr6:66399896-66399897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6923019 | chr6:66399897-66399898 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs140478156 | chr6:66399898-66399899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182124596 | chr6:66399901-66399902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558849178 | chr6:66399924-66399925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572620765 | chr6:66399944-66399945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369783064 | chr6:66399978-66399979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539898993 | chr6:66399982-66399983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560200730 | chr6:66399995-66399996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528871124 | chr6:66400009-66400010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144324066 | chr6:66400068-66400069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562758455 | chr6:66400118-66400119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555625597 | chr6:66400125-66400126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545793978 | chr6:66400214-66400215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187154692 | chr6:66400241-66400242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs551724506 | chr6:66400278-66400279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571308178 | chr6:66400284-66400285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs527490968 | chr6:66400296-66400297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139461452 | chr6:66400312-66400313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113600627 | chr6:66400348-66400349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534416576 | chr6:66401811-66401812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538239307 | chr6:66401813-66401814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558492829 | chr6:66401842-66401843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139598224 | chr6:66401889-66401890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375969312 | chr6:66401903-66401904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573820438 | chr6:66401982-66401983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534751220 | chr6:66402110-66402111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149900232 | chr6:66402117-66402118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143886106 | chr6:66402123-66402124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73437919 | chr6:66402128-66402129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs116897828 | chr6:66402129-66402130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114372552 | chr6:66402171-66402172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552959469 | chr6:66402189-66402190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66399600-66400400 | Enhancers | Placenta | Placenta |
2 | chr6:66401800-66402200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
3 | chr6:66402200-66403400 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
4 | chr6:66403600-66403800 | Enhancers | Rectal Mucosa Donor 29 | rectum |
5 | chr6:66408400-66408800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr6:66408800-66409200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr6:66409200-66412000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr6:66410000-66411000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr6:66410000-66411200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr6:66410400-66411000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
11 | chr6:66410600-66411000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
12 | chr6:66411000-66411400 | Active TSS | Pancreatic Islets | Pancreatic Islet |
13 | chr6:66411400-66412800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr6:66412800-66413600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
15 | chr6:66413600-66413800 | Flanking Active TSS | Pancreatic Islets | Pancreatic Islet |
16 | chr6:66413800-66414000 | Active TSS | Pancreatic Islets | Pancreatic Islet |
17 | chr6:66413800-66414800 | Enhancers | A549 | lung |